Literature DB >> 3365073

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

.   

Abstract

The National High Blood Pressure Education Program has released three Joint National Committee reports and a task force report on the detection, evaluation, and treatment of high blood pressure. Like its predecessors, the 1988 Joint National Committee report was developed using the consensus process; it is based on the latest scientific research and reflects the state of the art regarding hypertension management. This report updates findings of previous reports in several respects: it broadens the step-care approach to provide more flexibility for clinicians; encourages greater patient involvement in the treatment program; emphasizes a consideration of the quality of life in the management of patients; and addresses the cost of care. It also provides more emphasis on control of other risk factors for cardiovascular disease; includes a discussion of the new cholesterol guidelines; recommends a reduction in alcohol consumption; and discusses the use of calcium and fish oil supplementation. This document expands earlier reports on special populations, including blacks and other racial and ethnic minority groups, young and elderly patients, pregnant patients, surgical candidates, and hypertensive patients with cerebrovascular disease, coronary artery disease, left ventricular hypertrophy, congestive heart failure, peripheral vascular disease, renal disease, chronic obstructive pulmonary disease or bronchial asthma, gout, diabetes mellitus, and hyperlipidemia. The report also updates previous drug tables to include new drugs, revised recommended doses of some drugs, and drug interactions. Consideration of step-down therapy after blood pressure has been controlled is suggested. This report is intended as a guide for practicing physicians and other health professionals in their care of hypertensive patients and as a reference for those participating in the many community high blood pressure control programs throughout the country.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365073

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  137 in total

Review 1.  Old antihypertensive agents-diuretics and beta-blockers: do we know how and in whom they lower blood pressure?

Authors:  D A Sica
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study.

Authors:  E Odding; H A Valkenburg; H J Stam; A Hofman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Reflections on the U.S. Preventive Services Task Force recommendations for screening for hypertension and hypercholesterolemia.

Authors:  P K Whelton
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

4.  Characteristics of gouty arthritis in the Guatemalan population.

Authors:  C O Garcia; A G Kutzbach; L R Espinoza
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 5.  Is salt restriction necessary in hypertensive patients treated with calcium antagonists?

Authors:  J Redon
Journal:  Drugs       Date:  1992       Impact factor: 9.546

6.  Comparison of effects of enalapril and captopril on serum potassium concentration in the treatment of malignant hypertension.

Authors:  T Tsuchihashi; I Abe; A Tsukashima; K Kobayashi; M Ueno; M Fujishima
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 7.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

Review 8.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

9.  A comparison of results of a national cholesterol and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among Americans.

Authors:  F W Fridinger; A W Jackson; J Andresen
Journal:  J Community Health       Date:  1992-08

Review 10.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.